UBS Maintains Buy on Aptiv, Lowers Price Target to $62

Benzinga Newsdesk www.benzinga.com Neutral 56.4%

Neg 0% Neu 56.4% Pos 0%

UBS analyst Joseph Spak maintains Aptiv (NYSE:APTV) with a Buy and lowers the price target from $80 to $62.

Comments

No comments yet. Be the first!